Clinical trial
The Study on the Efficacy of tDCS Stimulation of the Cerebellum Combined With XingNaoJing Injection in Patients With Consciousness Disorders After Cranial Injury
NCT06927336 is registered in ClinicalTrials.gov with The Second Affiliated Hospital of Kunming Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Study on the Efficacy of tDCS Stimulation of the Cerebellum Combined With XingNaoJing Injection in Patients With Consciousness Disorders After Cranial Injury
- Lead sponsor
- The Second Affiliated Hospital of Kunming Medical University
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- April 25, 2025
- Completion date
- December 30, 2026
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
brain injury, cerebellum, disturbance of consciousness, tdcs